Short Courses*

March 1-3, 2020 | Moscone South Convention Center

Cambridge Healthtech Institute is pleased to offer short courses taking place on Sunday-Tuesday at the Moscone South Convention Center. The short courses are designed to be instructional, interactive, and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference programs that take place Monday-Wednesday.

Sunday, March 1 | 2:00 - 5:00 pm (Afternoon Short Courses)

SC1: Trends and Factors Impacting the Genetic Testing Landscape

Jeanette McCarthy, MPH, PhD, Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

SC2: Development and Implementation of NGS Diagnostics for Precision Medicine

Karl V. Voelkerding, MD, Professor, Pathology, University of Utah; Medical Director for Genomics and Bioinformatics, ARUP Laboratories

Additional Instructors to be Announced

SC3: Targeted Protein Degradation as a New Therapeutic Approach

Alexander Statsyuk, PhD, Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

Shaomeng Wang, PhD, Warner-Lambert/Parke-Davis Professor of Medicine, Pharmacology and Medicinal Chemistry; Co-Director, Molecular Therapeutics Program and Director, Cancer Drug Discovery Program, University of Michigan 

Ingrid Wertz, MD, PhD, Senior Scientist, Departments of Molecular Oncology and Early Discovery Biochemistry, Genentech, Inc.

SC4: Introduction to Data Visualization for Biomedical Applications

Nils Gehlenborg, PhD, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School

Alexander Lex, PhD, Assistant Professor, SCI Institute, School of Computing, University of Utah

SC5: Artificial Intelligence and Machine Learning in Drug Discovery and Development – Part 1

Michael Liebman, PhD, Managing Director, IPQ Analytics, LLC

Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan

Shruthi Bharadwaj, PhD, Senior Scientist, Novartis Oncology Precision Medicine

Additional Instructors to be Announced

SC6: Translating CTCs and ctDNA for Clinical Use

Sonya Parpart-Li, PhD, RAC, Associate Director, Product Management, GRAIL, Inc.

Gozde Durmus, PhD, Assistant Professor, Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine

Prachi Kothari, DO, Assistant Attending, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

SC7: A Primer on Digital Biomarkers and Measurement in the Connected Era

Andy Coravos, CEO & Co-Founder, Elektra Labs

Mark Shervey, Vice President, Engineering, Elektra Labs

Christine Manta, MS, RD, Research Project Manager, Elektra Labs

Sunday, March 1 | 5:30 - 8:30 pm (Dinner Short Courses)

SC9: Companion Diagnostics for Immuno-Oncology

Ken Emancipator, MD, Executive Medical Director, Companion Diagnostics & Translational Medicine, Merck & Co., Inc.

Deepti Aurora-Garg, Director, Companion Diagnostics, Merck & Co., Inc.

Mary J. Savage, Scientific Director, Merck & Co., Inc.

SC10: Microfluidics and Other Devices for POCT

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Additional Instructors to be Announced

SC11: Genome Editing with CRISPR: Toward Novel Research, Translational, and Clinical Applications

Serguei Kozlov, PhD, MBA, PMP, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)

SC12: Liquid Biopsy Technologies and Applications

John Simmons, PhD, Vice President, Translational Medicine, Personal Genome Diagnostics

SC13: Artificial Intelligence and Machine Learning in Drug Discovery and Development – Part 2

Michael Liebman, PhD, Managing Director, IPQ Analytics, LLC

Kuan-Fu Ding, MSc, PhD, CSO and CTO, Cubismi, Inc.

Pankaj Agarwal, PhD, Chief Computational Biologist, BioInfi

Deepak Kumar Rajpal, PhD, Head, Bioinformatics, Translational Sciences, Sanofi

Stefan Harrer, PhD, Manager and Research Staff Member, Brain-Inspired Computing, IBM Research; Adjunct Professor, School of Engineering and Information Science, University of Technology Sydney

SC14: Hands-On with Biomedical Data Visualization Tools and Programming Libraries

Nils Gehlenborg, PhD, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School

Alexander Lex, PhD, Assistant Professor, SCI Institute, School of Computing, University of Utah

Monday, March 2 | 8:00 - 11:00 am (Morning Short Courses)

SC17: NGS as a Testing Platform: Technology, Clinical Applications, and Global Standardization Strategies

Birgit Funke, PhD, FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor, Pathology, Harvard Medical School

Madhuri Hegde, PhD, Vice President, CSO, Global Lab Services, PerkinElmer, Inc.; Adjunct Professor, Emory University

SC18: Commercialization Boot Camp for Diagnostics: State of the State**

Harry Glorikian, MBA, General Partner, New Ventures Funds

Stan Skrzypczak, MS, MBA, Former Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.

SC19: NGS for Infectious Disease Diagnostics

Charles Chiu, MD, PhD, Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, Clinical Microbiology Laboratory, University of California, San Francisco

SC20: Digital Pathology: A-Z for Beginners

Matthew G. Hanna, MD, Clinical Instructor, Breast and Informatics, Department of Pathology, Memorial Sloan Kettering Cancer Center

SC21: Liquid Biopsy: Detection, Characterization, and Clinical Applications of Circulating Biomarkers

Catherine Alix-Panabières, PhD, Director, Laboratory of Rare Human Circulating Cells (LCCRH), Pathology and Onco-Biology Department, University Medical Center of Montpellier, France

Klaus Pantel, MD, Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Germany

SC22: Digital Medicine 101

Elena Izmailova, PhD, CSO, Koneksa Health

Joris van Dam, PhD, Head, Digital Therapeutics, Novartis Institutes for BioMedical Research

Tuesday, March 3 | 6:30 - 9:30 pm (Dinner Short Courses)

SC25: Coverage and Reimbursement for Advanced Diagnostics

Katherine Tynan, PhD, CEO, President, Tynan Consulting LLC

Lon Castle, MD, CMO, Molecular Genetics & Personalized Medicine, eviCore

Victoria Pratt, PhD, FACMG, Director, Pharmacogenomics and Molecular Genetics Laboratories, Medical and Molecular Genetics, Indiana University School of Medicine; President, Association of Molecular Pathology

SC26: Gene Editing and Base Editing for Cell Therapies

Clifford Steer, MD, Professor of Medicine and, Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School

Ross Wilson, PhD, Project Scientist & Principal Investigator, Innovative Genomics Institute, California Institute for Quantitative Biosciences, University of California, Berkeley

Additional Instructors to be Announced

SC27: Early Cancer Detection

Nicholas Dracopoli, PhD, CSO, DELFI Diagnostics

Girish Putcha, MD, CMO, Clinical Laboratory Director, Freenome

SC28: Global Companion Diagnostic Commercialization Boot Camp

Charles Mathews, Principal, ClearView Healthcare Partners

SC29: How Molecular Multiplex Testing for Infectious Disease Is Shaping Up

Lawrence J. Worden, Founder, Principal, IVD Logix

Lucy Hattingh, MBA, Principal, Lucy Hattingh Consulting

SC30: Digital Therapeutics 101

Shrawan Patel, Vice President & Head, Clinical Transformation, Rx.Health

Adam Kaufman, PhD, President & CEO, Canary Health

Ardy Arianpour, CEO & Co-Founder, Seqster

SC31: Multi-Modal Data Integration

Casey Greene, PhD, Associate Professor, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania

Additional Instructors to be Announced

*Separate Registration is required, or choose up to 3 in the All Access Pass.

* The program is subject to change without notice, due to unforeseen reason.